Harvard Bioscience ROA 2012-2026 | HBIO
Current and historical return on assets (ROA) values for Harvard Bioscience (HBIO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Harvard Bioscience ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2026-03-31 | $-0.01B | $0.08B | -11.39% |
| 2025-12-31 | $-0.06B | $0.08B | -70.44% |
| 2025-09-30 | $-0.05B | $0.09B | -58.08% |
| 2025-06-30 | $-0.06B | $0.11B | -54.55% |
| 2025-03-31 | $-0.06B | $0.12B | -49.68% |
| 2024-12-31 | $-0.01B | $0.13B | -10.00% |
| 2024-09-30 | $-0.02B | $0.13B | -11.32% |
| 2024-06-30 | $-0.01B | $0.14B | -8.16% |
| 2024-03-31 | $-0.01B | $0.14B | -6.51% |
| 2023-12-31 | $0.00B | $0.14B | -2.12% |
| 2023-09-30 | $0.00B | $0.14B | -2.09% |
| 2023-06-30 | $-0.01B | $0.15B | -3.44% |
| 2023-03-31 | $0.00B | $0.15B | -1.35% |
| 2022-12-31 | $-0.01B | $0.15B | -6.61% |
| 2022-09-30 | $-0.01B | $0.16B | -4.50% |
| 2022-06-30 | $0.00B | $0.16B | -2.54% |
| 2022-03-31 | $-0.01B | $0.16B | -3.82% |
| 2021-12-31 | $0.00B | $0.16B | 0.00% |
| 2021-09-30 | $0.00B | $0.15B | -1.30% |
| 2021-06-30 | $0.00B | $0.15B | -1.96% |
| 2021-03-31 | $-0.01B | $0.15B | -3.29% |
| 2020-12-31 | $-0.01B | $0.15B | -5.87% |
| 2020-09-30 | $-0.01B | $0.16B | -4.50% |
| 2020-06-30 | $-0.01B | $0.16B | -5.67% |
| 2020-03-31 | $-0.01B | $0.16B | -4.31% |
| 2019-12-31 | $0.00B | $0.17B | -2.41% |
| 2019-09-30 | $0.00B | $0.17B | -1.20% |
| 2019-06-30 | $0.00B | $0.17B | 0.60% |
| 2019-03-31 | $0.00B | $0.17B | 0.00% |
| 2018-12-31 | $0.00B | $0.17B | -1.19% |
| 2018-09-30 | $0.00B | $0.15B | -2.62% |
| 2018-06-30 | $0.00B | $0.14B | -2.88% |
| 2018-03-31 | $0.00B | $0.13B | -2.40% |
| 2017-12-31 | $0.00B | $0.11B | 0.00% |
| 2017-09-30 | $0.00B | $0.11B | -1.84% |
| 2017-06-30 | $0.00B | $0.11B | -3.67% |
| 2017-03-31 | $-0.01B | $0.11B | -4.54% |
| 2016-12-31 | $-0.01B | $0.11B | -4.42% |
| 2016-09-30 | $-0.02B | $0.12B | -18.10% |
| 2016-06-30 | $-0.02B | $0.12B | -16.46% |
| 2016-03-31 | $-0.02B | $0.13B | -14.87% |
| 2015-12-31 | $-0.02B | $0.13B | -14.42% |
| 2015-09-30 | $0.00B | $0.14B | -1.47% |
| 2015-06-30 | $0.00B | $0.14B | 0.00% |
| 2015-03-31 | $0.00B | $0.14B | 0.74% |
| 2014-12-31 | $0.00B | $0.14B | 2.20% |
| 2014-09-30 | $0.00B | $0.14B | 1.47% |
| 2014-06-30 | $0.00B | $0.14B | 0.00% |
| 2014-03-31 | $0.00B | $0.14B | -0.71% |
| 2013-12-31 | $0.00B | $0.14B | -1.42% |
| 2013-09-30 | $0.00B | $0.14B | 0.00% |
| 2013-06-30 | $0.00B | $0.14B | 0.73% |
| 2013-03-31 | $0.00B | $0.13B | 1.51% |
| 2012-12-31 | $0.00B | $0.13B | 2.28% |
| 2012-09-30 | $0.00B | $0.13B | 2.31% |
| 2012-06-30 | $0.00B | $0.13B | 2.33% |
| 2012-03-31 | $0.00B | $0.13B | 2.33% |
| 2011-12-31 | $0.00B | $0.13B | 3.13% |
| 2011-09-30 | $0.01B | $0.13B | 3.93% |
| 2011-06-30 | $0.02B | $0.13B | 14.34% |
| 2011-03-31 | $0.02B | $0.12B | 15.97% |
| 2010-12-31 | $0.02B | $0.11B | 16.74% |
| 2010-09-30 | $0.02B | $0.11B | 19.27% |
| 2010-06-30 | $0.01B | $0.11B | 8.53% |
| 2010-03-31 | $0.01B | $0.10B | 6.97% |
| 2009-12-31 | $0.01B | $0.09B | 7.45% |
| 2009-09-30 | $0.01B | $0.09B | 5.71% |
| 2009-06-30 | $0.01B | $0.08B | 6.04% |
| 2009-03-31 | $0.00B | $0.09B | 3.51% |
| 2008-12-31 | $0.00B | $0.09B | 2.24% |
| 2008-09-30 | $0.00B | $0.09B | -1.07% |
| 2008-06-30 | $0.00B | $0.10B | -1.04% |
| 2008-03-31 | $0.00B | $0.10B | -1.05% |
| 2007-12-31 | $0.00B | $0.09B | -2.12% |
| 2007-09-30 | $0.00B | $0.09B | -3.23% |
| 2007-06-30 | $0.00B | $0.09B | -4.37% |
| 2007-03-31 | $0.00B | $0.09B | -2.17% |
| 2006-12-31 | $0.00B | $0.09B | -1.09% |
| 2006-09-30 | $-0.01B | $0.09B | -8.72% |
| 2006-06-30 | $-0.01B | $0.10B | -7.31% |
| 2006-03-31 | $-0.03B | $0.10B | -31.16% |
| 2005-12-31 | $-0.03B | $0.11B | -28.96% |
| 2005-09-30 | $-0.02B | $0.12B | -17.96% |
| 2005-06-30 | $-0.02B | $0.13B | -16.99% |
| 2005-03-31 | $0.00B | $0.14B | 1.47% |
| 2004-12-31 | $0.00B | $0.14B | 1.47% |
| 2004-09-30 | $0.00B | $0.13B | 2.25% |
| 2004-06-30 | $0.00B | $0.13B | 2.32% |
| 2004-03-31 | $0.00B | $0.13B | 3.21% |
| 2003-12-31 | $0.01B | $0.12B | 4.18% |
| 2003-09-30 | $0.00B | $0.12B | 1.74% |
| 2003-06-30 | $0.00B | $0.11B | 0.94% |
| 2003-03-31 | $0.00B | $0.10B | 1.02% |
| 2002-12-31 | $0.00B | $0.09B | 1.11% |
| 2002-09-30 | $0.00B | $0.08B | 2.39% |
| 2002-06-30 | $0.00B | $0.08B | 2.47% |
| 2002-03-31 | $0.00B | $0.08B | -5.10% |
| 2001-12-31 | $-0.01B | $0.07B | -6.78% |
| 2001-09-30 | $0.03B | $0.07B | 42.65% |
| 2001-06-30 | $0.01B | $0.06B | 21.72% |
| 2001-03-31 | $-0.05B | $0.04B | -122.45% |
| 2000-12-31 | $-0.05B | $0.02B | -239.02% |
| 2000-09-30 | $-0.08B | $0.01B | -745.45% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $0.019B | $0.087B |
| HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bruker (BRKR) | United States | $5.722B | 20.54 |
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |